CoChat

Dual CD4-based CAR T cells with distinct costimulatory domains mitigate HIV pathogenesis in vivo

Open access
Maldini, Colby R., Claiborne, Daniel T., Okawa, Ken, Chen, Tao, Dopkin, Derrick L., Shan, Xiaochuan, Power, Karen A., Trifonova, Radiana T., Krupp, Katharine, Phelps, Meredith, Vrbanac, Vladimir D., Tanno, Serah, Bateson, Timothy, Leslie, George J., Hoxie, James A., Boutwell, Christian L., Riley, James L., Allen, Todd M. · 2020 · Nature Medicine
Cited by 125

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Abstract

An effective strategy to cure HIV will likely require a potent and sustained antiviral T cell response. Here we explored the utility of chimeric antigen receptor (CAR) T cells, expressing the CD4 ectodomain to confer specificity for the HIV envelope, to mitigate HIV-induced pathogenesis in bone marrow, liver, thymus (BLT) humanized mice. CAR T cells expressing the 4-1BB/CD3-ζ endodomain were insufficient to prevent viral rebound and CD4+ T cell loss after the discontinuation of antiretroviral therapy. Through iterative improvements to the CAR T cell product, we developed Dual-CAR T cells that simultaneously expressed both 4-1BB/CD3-ζ and CD28/CD3-ζ endodomains. Dual-CAR T cells exhibited expansion kinetics that exceeded 4-1BB-, CD28- and third-generation costimulated CAR T cells, elicited effector functions equivalent to CD28-costimulated CAR T cells and prevented HIV-induced CD4+ T cell loss despite persistent viremia. Moreover, when Dual-CAR T cells were protected from HIV infection through expression of the C34-CXCR4 fusion inhibitor, these cells significantly reduced acute-phase viremia, as well as accelerated HIV suppression in the presence of antiretroviral therapy and reduced tissue viral burden. Collectively, these studies demonstrate the enhanced therapeutic potency of a novel Dual-CAR T cell product with the potential to effectively treat HIV infection. Chimeric antigen receptor T cells targeting HIV-infected cells prevent T cell loss and reduce virus in blood and tissues of HIV-infected humanized mice, highlighting a path toward a cell-based therapy for HIV infection.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41591-020-1039-5

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 16 references

Cited by

See all 125

Metadata

Authors
Maldini, C. R., Claiborne, D. T., Okawa, K., Chen, T., Dopkin, D. L., Shan, X., Power, K. A., Trifonova, R. T., Krupp, K., Phelps, M., Vrbanac, V. D., Tanno, S., Bateson, T., Leslie, G. J., Hoxie, J. A., Boutwell, C. L., Riley, J. L., & Allen, T. M.
Venue
Nature Medicine
Published
2020-08-31
Volume
26
Issue
11
Pages
1776-1787
ISSN
  • 1078-8956 (ISSN-L)
  • 1546-170X
OpenAlex
W3081862669
Cited by
125
References
16
FWCI
6.68
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Dual CD4-based CAR T cells with distinct costimulatory domains mitigate HIV pathogenesis in vivo. https://app.cochat.ai/papers/10.1038/s41591-020-1039-5
The paper
Maldini, C. R., Claiborne, D. T., Okawa, K., Chen, T., Dopkin, D. L., Shan, X., Power, K. A., Trifonova, R. T., Krupp, K., Phelps, M., Vrbanac, V. D., Tanno, S., Bateson, T., Leslie, G. J., Hoxie, J. A., Boutwell, C. L., Riley, J. L., & Allen, T. M. (2020). Dual CD4-based CAR T cells with distinct costimulatory domains mitigate HIV pathogenesis in vivo. Nature Medicine. https://doi.org/10.1038/s41591-020-1039-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.